CONTEXT AND OBJECTIVE: Dendritic cell maturation is considered essential for starting an immune response. The CD83 antigen is an important marker of dendritic cell maturation.
intrODUctiOn Fibroadenoma is the most common benign tumor in the human breast, especially in women younger than 35 years old. 1 Histologically, it presents with both epithelial and conjunctive components, and is therefore considered to be a mixed lesion. The principal characteristic of this lesion is the presence of fibrous stroma with low cellularity that lacks cell atypias. 2 The main function and most important feature of the immune system is its ability to recognize microorganisms, neoplastic cells and other substances as foreign to the organism. This occurs via identification of antigens that may be recognized as noxious. One of the main processes in this recognition occurs through a specialized protein known as the major histocompatibility complex (MHC); this protein has the capacity to bind peptides and to present them to T cells. There are two main types of MHC proteins, class I and class II, which can present peptides to cytolytic lymphocytes (CD8+) or to auxiliary lymphocytes (CD4+), respectively. Dendritic cell maturation is considered essential for the beginning of the immune response. 4 This maturation is completed after interaction with the T cell and is characterized by loss of endocytic capacity and the expression of accessory molecules that interact with the T lymphocyte receptors and function as costimulators, thereby increasing their adhesion and signaling. 5 One of these costimulatory molecules is called CD83 and is a marker associated with dendritic cell maturation, 6, 7 CD83 is a member of the immunoglobulin superfamily, and is 45 kDa in size. It is also observed in dendritic cells in peripheral blood. 8 It is known that abnormal cell behavior can lead to emergence of fibroadenoma presenting with proliferation of conjunctive and epithelial tissues. 9 The action of the immune sys- 
METHODS
This was a retrospective study, in which 28 women presenting cases of benign nodules in the breasts were selected. All these women received care from the Benign Diseases Sector of the Discipline of Mastology of the Department of Gynecology of a public university hospital.
The patients were between the ages of 16 and 49 years, and all were of reproductive age. Their clinical, gynecological and colpocytological tests were normal, with the exception of the benign neoplasm in the breast. Patients with endocrine diseases, pregnant women and women who had breastfed within the last twelve months were excluded. 10, 11 This retrospective study involved immunohistochemical analysis on histopathological material that was obtained by means of outpatient surgical procedures between January and December 2006. The patients were placed under local anesthesia, and lumpectomy was performed with a safety margin going into the adjacent breast tissue by at least 1 cm from the lesion, and both types of materials obtained (breast lump and the breast parenchyma tissue adjacent to the lesion) were evaluated histopathologically.
10,12
The biopsies were separated into two groups initially, according to the type of tissue to be analyzed. The first group (group A) included breast lump material (fibroadenomas), and the second group (group B) included the breast parenchyma tissue adjacent to the lesion. The whole material was prepared in a paraffin block for histopathological analysis. The slides were prepared using a primary CD83 antibody and a secondary antibody (CD83 antibody SEROTEC MCA 1582), and then analyzed.
The slides were prepared using a microtome, by taking slices of thickness 2 mm to 3 mm from the paraffin block. These paraffin slices were mounted on slides that had been prepared with silane-APTS (3-aminopropyltriethoxysilane The next phase in the preparation was antigen recovery from the paraffin-embedded tissue samples, which is necessary for most of the epitopes investigated. 13 This was accomplished by microwave irradiation, in which the slides were incubated and buffered with 10 mM citrate (pH 5.0) in a microwave oven at maximum power for two sessions of nine minutes each, with a freezing interval of 20 minutes, followed by washing with distilled water.
14 Subsequently, the slides were subjected to two 10-minute baths in 3% hydrogen peroxide (H 2 O 2 ) in methanol, followed by washing with distilled water and buffering using phosphatebuffered saline (PBS) solution. This was used to block the tissue endogenous peroxidase.
The slides were prepared with specific antibodies using the per- for one minute and washed with distilled water. They were then immersed quickly four times in 0.5% ammonium hydroxide, and washed with distilled water; the slides were dehydrated first in 50%
ethanol, followed by 80% ethanol, 95% ethanol, 100% ethanol and finally, three times in xylol. Coverslips were affixed using Entellan, for analysis under an ordinary optical microscope.
As previously discussed, the hormonal actions of estrogen and progesterone can influence cell proliferation in fibroadenomas and breast duct epithelium. Therefore, considering the clinical features presented in this study, the sample was further divided in two groups in relation to the use of hormonal contraceptives: group C consisted of 21 cases of women who were not using hormonal contraceptives, while group D consisted of eight women who were using oral hormonal contraceptives. The analysis of CD83 antigen expression in these cells was accomplished by means of random manual counting using optical microscopy, and the results were categorized according to whether the anti- Table 1 ). All of the women in the study were of reproductive age, and eight of them were using hormonal contraceptives.
Most of the fibroadenomas (19 cases) were solitary, but in five cases, the women had two fibroadenomas, and in two cases the patients had three fibroadenomas each. In another single case there were four lumps, and one other woman presented seven fibroadenomas. In nine of the cases of multiple fibroadenomas, five were bilateral. The largest diameter of the lesions ranged from 0.5 cm to 3 cm (average: 1.52 cm).
Other clinical features, such as age at first childbirth and smoking, were considered. However, they did not present statistical relevance ( Table 1 ).
The value of CD83 expression in the fibroadenoma cells and in the adjacent breast cells was analyzed. Positive antigen expression was observed (Figures 1 and 2 ), on average, in 365.52 (standard deviation [SD] ± 133.13) of the fibroadenoma cells and in 189.59 (SD ± 140.75) of the adjacent breast tissue cells (P < 0.001).
In the fibroadenomas, negative antigen expression or non-expression was observed in 134.14 (SD ± 133.40) of the cells (Figure 3) , while in the adjacent breast tissue 310.41 (SD ± 134.85) of the cells did not express the CD83 antigen (P < 0.001). From analysis on these results, we observed that the difference in CD83 expression between groups A and B was significant (P < 0.001). Additionally, the negative expression or non-expression of CD83 was also significantly different (P < 0.001). These results confirmed that CD83 expression was much more evident in the fibroadenoma cells (P < 0.001). These values were analyzed in an absolute manner, and they are shown in Table 2 .
The influence of the use of oral hormonal contraceptives on the cell expression of CD83 was analyzed by using the data obtained from groups C and D. The results from these two groups were analyzed as above. Table 4 .
The analysis on the results from groups C and D showed that CD83 expression in the fibroadenoma cells was more evident than in the adjacent breast tissue cells, and that in both groups there was a statistically significant difference in the results (respectively P < 0.001 and P = 0.044). In other words, the use of hormonal contraceptives did not appear to have an influence on CD83 expression in this analysis.
Several clinical factors were also considered, such as age, family history of breast cancer, parity, age at first childbirth, diameter of the lump (fibroadenoma), number of fibroadenomas in each patient (multiple or solitary) and smoking ( Table 1) . The age at first childbirth and smoking appeared to be homogeneous in the samples studied, and therefore lacking in clinical meaning. The other observed features were analyzed statistically, and the results are shown in Table 5 . The only feature that presented statistical relevance in relation to CD83 expression was parity and this was only true in relation to the tissue adjacent to the fibroadenoma. 25 Chlamydia infections 26 and allergic diseases such as atopic eczema and asthma. 27, 28 Many possibilities may open up through studies on the immune system and dendritic cells, thereby making it possible to discover new treatments and vaccines. antigen-presenting function, and they capture tumor antigens and introduce them to the lymphocyte after migration to the secondary lymph nodes where the immune response begins. 16 There is a change in the receptor repertoire of the dendritic cell that facilitates its ability to change its location depending on its maturation phase.
This increases its effectiveness at finding, capturing and presenting antigens. This study evaluated clinical features that could influence this CD83 expression. The results showed that, of the factors analyzed, the only one that influenced CD83 expression in breast tissue adjacent to the fibroadenoma was the patient's parity. Positive expression of CD83 was more evident in the adjacent breast tissue of the nulliparous women (P = 0.042). There is a coherent association between these data and previous knowledge, which indicates the age at the first childbirth has an influence on breast cancer risk. Having the first childbirth at a younger age reduces the risk of breast cancer. 29 Additionally, large parity can reduce this risk. 30 The first pregnancy indicates the time at which the physiological maturation of the breast gland is completed, presumably from the intense estrogen, progesterone, HCG and prolactin stimulation. The maturation begins with ductal ramification and growth of the lobule-alveolar structure, until the formation of multiple alveoli is complete and consequent glandular epithelium proliferation occurs. This development is followed by the formation of glandular structures, lobule-alveolar system maturation and secretory epithelium maturation. 31 These breast tissue modifications, associated with obstetric factors, affect cytological characteristics and the risk of breast cancer, thus indicating that the gland is influenced by pregnancy and may develop the capacity to recognize antigens and activate the immune system.
CONCLUSIONS
The expression of CD83 in the fibroadenoma cells was positive and greater than in the breast tissue adjacent to the lump (P < 0.001), when analyzed by means of immunohistochemistry. New studies should be conducted in order to define the clinical meaning of this result and investigate the possibility that this knowledge may be important in the pursuit of new immune therapies against breast tumors.
The expression of CD83 in the breast tissue adjacent to the fibroadenoma was influenced by whether the patient was nulliparous or had already had at least one full term pregnancy, and it was significantly greater in nulliparous women (P = 0.042). In this context, the repercussions of pregnancy in breast tissue may affect the immune response; this needs to be better characterized, given that CD83 expression in breast tissue adjacent to the fibroadenoma was influenced by the patient's history of pregnancy (P = 0.042).
